131 related articles for article (PubMed ID: 31419362)
1. Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer.
Wali GN; Gibbons E; Kelly L; Reed JR; Matin RN
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):491-501. PubMed ID: 31419362
[TBL] [Abstract][Full Text] [Related]
2. The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-metastatic skin cancers.
Burdon-Jones D; Gibbons K
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1109-13. PubMed ID: 22909179
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
[TBL] [Abstract][Full Text] [Related]
4. Creation of a quality of life instrument for nonmelanoma skin cancer patients.
Rhee JS; Matthews BA; Neuburg M; Burzynski M; Nattinger AB
Laryngoscope; 2005 Jul; 115(7):1178-85. PubMed ID: 15995503
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcome measures for facial skin cancer: a systematic review and evaluation of the quality of their measurement properties.
Dobbs TD; Samarendra H; Hughes S; Hutchings HA; Whitaker I
Br J Dermatol; 2019 May; 180(5):1018-1029. PubMed ID: 30362522
[TBL] [Abstract][Full Text] [Related]
7. Behavior modification and risk perception in patients with nonmelanoma skin cancer.
Rhee JS; Davis-Malesevich M; Logan BR; Neuburg M; Burzynski M; Nattinger AB
WMJ; 2008 Apr; 107(2):62-8. PubMed ID: 18593080
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcome measures in nonmelanoma skin cancer of the face: a systematic review.
Bates AS; Davis CR; Takwale A; Knepil GJ
Br J Dermatol; 2013 Jun; 168(6):1187-94. PubMed ID: 23387431
[TBL] [Abstract][Full Text] [Related]
9. Quality of life issues in nonmetastatic skin cancer.
Burdon-Jones D; Thomas P; Baker R
Br J Dermatol; 2010 Jan; 162(1):147-51. PubMed ID: 19796177
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal, mixed method study to look at the experiences and knowledge of non melanoma skin cancer from diagnosis to one year.
Bath-Hextall F; Jenkinson C; Kumar A; Leonardi-Bee J; Perkins W; Cox K; Glazebrook C
BMC Dermatol; 2013 Oct; 13():13. PubMed ID: 24164857
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
[TBL] [Abstract][Full Text] [Related]
12. A structured review of patient-reported outcome measures for patients with skin cancer, 2013.
Gibbons E; Casañas i Comabella C; Fitzpatrick R
Br J Dermatol; 2013 Jun; 168(6):1176-86. PubMed ID: 23488455
[TBL] [Abstract][Full Text] [Related]
13. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
[No Abstract] [Full Text] [Related]
14. Comparison of quality of life between melanoma and non-melanoma skin cancer patients.
Sampogna F; Paradisi A; Iemboli ML; Ricci F; Sonego G; Abeni D
Eur J Dermatol; 2019 Apr; 29(2):185-191. PubMed ID: 31106760
[TBL] [Abstract][Full Text] [Related]
15. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
16. How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures?
Aguirre E; Kang S; Hoare Z; Edwards RT; Orrell M
Qual Life Res; 2016 Jan; 25(1):45-9. PubMed ID: 26163146
[TBL] [Abstract][Full Text] [Related]
17. Cardiff cardiac ablation patient-reported outcome measure (C-CAP): validation of a new questionnaire set for patients undergoing catheter ablation for cardiac arrhythmias in the UK.
White J; Withers KL; Lencioni M; Carolan-Rees G; Wilkes AR; Wood KA; Patrick H; Cunningham D; Griffith M
Qual Life Res; 2016 Jun; 25(6):1571-83. PubMed ID: 26659900
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessment in patients with nonmelanoma skin cancer - psychometric validation of the EORTC QLQ-C30 questionnaire.
Müller K; Karrer S; Szeimies RM; Steinbauer J; Kohl E; Steinbauer D; Zeman F; Berneburg M; Koller M
J Dtsch Dermatol Ges; 2017 Nov; 15(11):1090-1100. PubMed ID: 29106018
[TBL] [Abstract][Full Text] [Related]
19. Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer.
Chernyshov PV; Lallas A; Tomas-Aragones L; Arenbergerova M; Samimi M; Manolache L; Svensson A; Marron SE; Sampogna F; Spillekom-vanKoulil S; Bewley A; Forsea AM; Jemec GB; Szepietowski JC; Augustin M; Finlay AY
J Eur Acad Dermatol Venereol; 2019 May; 33(5):816-827. PubMed ID: 30963614
[TBL] [Abstract][Full Text] [Related]
20. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
